Jupiter Ebit from 2010 to 2024

JUNS Stock  USD 9.73  1.13  10.41%   
Jupiter Neurosciences, EBIT yearly trend continues to be comparatively stable with very little volatility. EBIT will likely drop to about -4.1 M in 2024. From the period from 2010 to 2024, Jupiter Neurosciences, EBIT quarterly data regression had mean square error of 364.6 B and mean deviation of  769,340. View All Fundamentals
 
EBIT  
First Reported
2010-12-31
Previous Quarter
-3.9 M
Current Value
-4.1 M
Quarterly Volatility
909.1 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Jupiter Neurosciences, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jupiter Neurosciences,'s main balance sheet or income statement drivers, such as Interest Expense of 298.9 K, Selling General Administrative of 2.8 M or Total Revenue of 199.5 K, as well as many indicators such as Price To Sales Ratio of 533, Dividend Yield of 0.0 or Days Sales Outstanding of 32.73. Jupiter financial statements analysis is a perfect complement when working with Jupiter Neurosciences, Valuation or Volatility modules.
  
Check out the analysis of Jupiter Neurosciences, Correlation against competitors.

Latest Jupiter Neurosciences,'s Ebit Growth Pattern

Below is the plot of the Ebit of Jupiter Neurosciences, Common over the last few years. It is Jupiter Neurosciences,'s EBIT historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Jupiter Neurosciences,'s overall financial position and show how it may be relating to other accounts over time.
Ebit10 Years Trend
Slightly volatile
   Ebit   
       Timeline  

Jupiter Ebit Regression Statistics

Arithmetic Mean(2,376,144)
Coefficient Of Variation(38.26)
Mean Deviation769,340
Median(1,851,594)
Standard Deviation909,085
Sample Variance826.4B
Range2.2M
R-Value(0.77)
Mean Square Error364.6B
R-Squared0.59
Significance0.0008
Slope(156,180)
Total Sum of Squares11.6T

Jupiter Ebit History

2024-4.1 M
2023-3.9 M
2022-3.4 M
2021-3.9 M

Other Fundumenentals of Jupiter Neurosciences,

About Jupiter Neurosciences, Financial Statements

Jupiter Neurosciences, shareholders use historical fundamental indicators, such as Ebit, to determine how well the company is positioned to perform in the future. Although Jupiter Neurosciences, investors may analyze each financial statement separately, they are all interrelated. The changes in Jupiter Neurosciences,'s assets and liabilities, for example, are also reflected in the revenues and expenses on on Jupiter Neurosciences,'s income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
EBIT-3.9 M-4.1 M
EBITDA-4.6 M-4.8 M
Ebt Per Ebit 1.24  0.97 
Ebit Per Revenue(16.92)(16.07)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Jupiter Stock Analysis

When running Jupiter Neurosciences,'s price analysis, check to measure Jupiter Neurosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jupiter Neurosciences, is operating at the current time. Most of Jupiter Neurosciences,'s value examination focuses on studying past and present price action to predict the probability of Jupiter Neurosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jupiter Neurosciences,'s price. Additionally, you may evaluate how the addition of Jupiter Neurosciences, to your portfolios can decrease your overall portfolio volatility.